Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14951 - 14975 of 15168 in total
Experimental
Investigational
Tyramine (4-hydroxyphenethylamine; para-tyramine, mydrial or uteramin) is a naturally occurring monoamine compound and trace amine derived from the amino acid tyrosine. Tyramine acts by inducing the release of catecholamine. An important characteristic of this product is its impediment to cross the blood-brain barrier which restrains its side effects to only...
Investigational
Nutraceutical
Matched Description: … hydroxyphenethylamine; para-tyramine, mydrial or uteramin) is a naturally occurring monoamine compound and
Etofibrate is a fibrate produced by the combination of clofibrate ester linked to niacin. These components separate in the body slowly allowing for pharmacokinetics similar to controlled-release formulations.
Experimental
Talinolol has been investigated for the basic science of Gastrointestinal Motility Disorder.
Investigational
BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational
Dapaconazole has been used in trials studying the treatment of Tinea Pedis.
Investigational
Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.
Investigational
LY2886721 has been used in trials studying the basic science of Alzheimer's Disease.
Investigational
Azeliragon has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
TBD has been used in trials studying the treatment of Adenocarcinoma.
Investigational
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Displaying drugs 14951 - 14975 of 15168 in total